The Food and Drug Administration (FDA) awarded a $39,857 firm-fixed-price purchase order contract to Mattek Corporation, a foreign-owned small business manufacturer of human tissue models, for the delivery of reconstructed human small intestine and pigmented epidermis microtissue samples and associated culture media. This procurement supports toxicological research at the FDA's National Center for Toxicological Research (NCTR). The contract requires 144 samples of each tissue type, featuring...
The U.S. Food and Drug Administration (FDA) awarded a $120,950.00 firm fixed-price purchase order contract to Tissuse GMBH, a for-profit organization based in Germany. The contract is for the development of a multi-organ human-on-a-chip system, with a period of performance ending on December 31, 2024. The contract does not have a set-aside designation. Based on the FDA's role in evaluating medical technologies, this contract is likely related to the agency's efforts to advance the development of...
This federal contract award, valued at $4,894.85, was issued by the Food and Drug Administration (FDA) to Government Scientific Source Inc., a for-profit small business organization based in Reston, Virginia. The contract is for the delivery of a 48R incubator with accessories, which aligns with the FDA's scientific research and medical testing programs. The contract was awarded under the Multiple Award Schedule (MAS) contract vehicle, specifically the Scientific Equipment and Services...
The Food and Drug Administration (FDA) awarded a $48,680.00 firm fixed price purchase order to Emulate Inc., a for-profit small business, for the purchase of Emulate Chip-S1 Basic Research Kits. This contract supports the FDA's regulatory science initiatives and advances the agency's work on non-animal testing approaches. The award has an ultimate completion date of August 21, 2025. Emulate Inc. has previously received federal grants, including a cooperative agreement from the Defense Advanced...
<p>The Department of Health and Human Services Food and Drug Administration awarded a firm fixed price purchase order contract to the University of Massachusetts, operating through its Office of Grant & Contract Administration, to assess changes in the human gut microbiome in relation to foodborne illness. The contract has a potential value of $129,937.29 and a completion date of September 29, 2018. There is no set-aside designation indicated for this contract.</p>
This is a $35,655.48 firm fixed price purchase order awarded by the National Institute of Environmental Health Sciences (NIEHS), a civilian agency under the Department of Health and Human Services, to Given Imaging Inc., a foreign-owned for-profit medical device company. The contract is for the provision of specialized gastrointestinal diagnostic products and maintenance services, including wireless pH monitoring systems, manometry catheters and probes, pillcam capsule endoscopy systems, and...
This $164,555.50 firm-fixed-price purchase order contract was awarded by the Food and Drug Administration (FDA), a civilian government agency, to Emulate Inc., a small business contractor, for the procurement of two Zoe Culture Modules and two Orb Hub Modules of the Human Emulation System. The award, made under a small business set-aside, supports the FDA's regulatory science initiatives and efforts to advance non-animal testing approaches. Emulate Inc. has a long history of providing...
This is a $3,526,785.00 definitive, firm fixed-price contract awarded by the Food and Drug Administration (FDA) to the Regents of the University of Michigan, doing business as the University of Michigan, for Prediction of In Vivo Performance Analysis Services. The contract has no set-aside designation. The University of Michigan is providing a range of research and development services under this contract, including developing high-performance computational models to simulate small intestine...
This is a $79,500 firm fixed-price purchase order contract awarded by the Food and Drug Administration (FDA), a civilian agency, to Nortis Inc., a for-profit manufacturer of biotechnology products and services. The contract is for the provision of a Parvivo System, which is an organ-on-a-chip technology. The contract has no set-aside designation and was awarded in September 2020, with a completion date of September 2021. Nortis Inc. has received prior federal grant awards from agencies such as...
The Food and Drug Administration (FDA) awarded a $465,096.00 firm fixed-price purchase order to Global Life Sciences Solutions USA LLC for the delivery of an XDR-50 single use bioreactor system or equivalent with accessories, training, and installation. The bioreactor system will support the FDA's Center for Drug Evaluation and Research Division of Product Quality Research. The contract has a two-year manufacturer's warranty and a performance period through May 18, 2025. This award was not set...